ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meunier, B.
Right arrow Articles by Launois, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meunier, B.
Right arrow Articles by Launois, B.

Ann Thorac Surg 1996;62:373-377
© 1996 The Society of Thoracic Surgeons


Original Articles: General Thoracic

Retrosternal Bypass Operation for Unresectable Squamous Cell Cancer of the Esophagus

Bernard Meunier, MD, Yorgos Spiliopoulos, MD, Christian Stasik, MD, Mohamed Lakéhal, MD, Yannick Malledant, MD, Bernard Launois, MD

Departments of Digestive Surgery and Intensive Care, Centre Hospitalier, Rennes, France

Accepted for publication April 9, 1996.

Background. A palliative bypass operation may be beneficial when severe dysphagia or tracheoesophageal fistula occurs after radiochemotherapy for unresectable tumor of the esophagus.

Methods. Thirty-two patients with an unresectable tumor of the esophagus underwent a palliative retrosternal gastric (29) or colonic (3) bypass operation with ligature of the lower esophagus (3) or drainage (27). Tracheoesophageal fistula was present at operation in 20 (62.5%), including 8 after radiochemotherapy.

Results. The overall operative mortality rate was 34.4%: 45% with tracheoesophageal fistula and 16.6% without (p< 0.01). Median intensive care and hospitalization times were 5 and 19 days, respectively. Median postoperative survival was 6 months (range, 53 to 492 days). Complications in 21 survivors were lung infections (seven), cervical fistulas (eight), and failure of the esophageal suture (two); 19 patients resumed oral nutrition, and quality of life was excellent in 6. All eight cervical fistulas regressed favorably. Postoperative radiotherapy or chemotherapy did not improve survival.

Conclusions. Despite the high operative mortality rate, bypass operation can provide good palliation and allow subsequent radiochemotherapy in selected patients with an unresectable tumor of the esophagus.




This article has been cited by other articles:


Home page
RadioGraphicsHome page
T. J. Kim, K. H. Lee, Y. H. Kim, S. W. Sung, S. Jheon, S.-k. Cho, and K. W. Lee
Postoperative Imaging of Esophageal Cancer: What Chest Radiologists Need to Know
RadioGraphics, March 1, 2007; 27(2): 409 - 429.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
B. P. Whooley, S. Law, S. C. Murthy, A. Alexandrou, K.-M. Chu, and J. Wong
The Kirschner Operation in Unresectable Esophageal Cancer: Current Application
Arch Surg, November 1, 2002; 137(11): 1228 - 1232.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.